PhG News | Penn Health Group

top of page

Home
About PhG
Brands
Events
Education
News
- PhG Press
- Press Releases
Find PhG
Contact Us
More

Use tab to navigate through the menu items.

Subscribe to Penn Health Group news!

Email

Thanks for subscribing!

PhG Press

Press Releases

The statements in this website have not been evaluated by the U.S. Food and Drug Administration. The FDA has NOT approved marijuana as a safe and effective drug for any indication. No product, service, device, therapy, or regimen described herein is intended to diagnose, treat, cure, or prevent any disease, health problem, or medical condition. Learn more about the FDA and marijuana at https://www.fda.gov/news-events/public-health-focus/fda-and-cannabis-research-and-drug-approval-process. Although the manufacture and distribution of medical cannabis and cannabis-infused or derived products by State-licensed facilities and possession and use by registered, qualifying patients may be permitted by various state laws, marijuana is a prohibited Schedule I controlled substance under federal law.

Cannabis and cannabis-infused or derived products may have side effects, including but not limited to increased heart rate, dizziness, lightheadedness, shallow breathing, loss of balance, slowed reaction time, increased appetite, effects on mood, etc. Please do NOT act in any manner potentially harmful or injurious to others while under the influence of cannabis or cannabis-infused or derived products, including without limitation driving a motor vehicle or operating machinery.

Penn Health Group is not a licensed practitioner and, therefore, is not prescribing or suggesting any specific product for any specific condition. Please contact your licenses practitioner with any questions about which products would be best for you.

bottom of page